For the Quarter Ending March 2024
North America
In Q1 2024, the pricing of Omeprazole in the North America region underwent notable fluctuations, influenced by various factors shaping market conditions. Throughout the quarter, the pricing trend exhibited a mixed pattern, characterized by shifts in both supply and demand dynamics, alongside external factors impacting the market. The price trajectory of Omeprazole in the region followed a nuanced pattern, marked by increases in January, declines in February, and subsequent increases again in March.
At the beginning of the quarter, Omeprazole prices surged due to heightened buying activity in downstream sectors such as pharmaceuticals and healthcare. Additionally, disruptions at two vital shipping chokepoints, namely the Suez Canal and the Panama Canal, led to increased costs for U.S. retailers, resulting in higher prices for consumers. Midway through the quarter, prices declined as cautious consumer attitudes towards the economy prevailed. Factors such as sluggish retail sales and subdued consumer spending contributed to this decline. Persistent inflationary pressures further exacerbated consumer caution, prompting a conservative approach to finances. However, prices rebounded slightly in March due to an improvement in business sentiments. This improvement was driven by a steady increase in new orders from end-users. Moreover, the resumption of factory activity in China following the conclusion of the Lunar New Year holidays prompted importers in the USA to swiftly place orders to replenish their inventories, perpetuating heightened demand and supporting the upward trajectory of prices.
Overall, the pricing environment for Omeprazole in Q1 2024 can be characterized as unstable, with fluctuations in prices driven by changes in demand, supply, and external factors. The latest quarter-ending price for Omeprazole in the USA was USD 62155/MT of Omeprazole (USP, FDA) CFR Houston.
Asia Pacific
In Q1 2024, the pricing dynamics of Omeprazole in the APAC region were influenced by various factors, resulting in a mixed trend throughout the quarter. Prices exhibited an upward trajectory in January, followed by a decline in February, and a subsequent rise again in March. During January, the rise in inquiries from the overseas market contributed to pushing prices upward. Additionally, disruptions in the global supply chain, particularly in shipping routes, led to slower shipments and delayed delivery of goods, resulting in a surge in freight charges and operational costs. Consequently, market suppliers adjusted their prices to maintain profit margins. Midway through the quarter, prices experienced a downturn in February due to dwindling enquiries and orders from key sectors like healthcare and pharmaceuticals. This drop in demand was largely spurred by the closure of numerous businesses during China's Spring Festival, leading to an excess supply situation. However, prices rebounded slightly towards the end of the quarter as the manufacturing sector showed signs of steady improvement, signaling a notable recovery in industrial activities following the conclusion of the Lunar New Year holiday. This revitalization in manufacturing was marked by a significant expansion in both supply and demand metrics, further bolstered by a resurgence in international demand, thereby strengthening the positive momentum in Omeprazole. The quarter-ending price for Omeprazole in China was recorded at USD 60900 per metric ton (USP, FDA) FOB Shanghai.
Europe
Omeprazole prices in the European market witnessed an upward trend during Q1 2024, attributed to various contributing factors. In France specifically, Omeprazole prices consistently rose throughout the quarter, primarily due to geopolitical tensions, logistical hurdles, and dwindling inventories. Despite these challenges, downstream industries maintained operational stability, leading to a sustained demand for Omeprazole and subsequent price hikes. Logistical challenges stemming from attacks on cargo ships in the Red Sea further exacerbated transportation disruptions, resulting in costlier and lengthier shipments. This factor compounded the upward pressure on prices. Moreover, recent data indicating a decrease in inflation rates across Europe instilled confidence among consumers, alleviating financial burdens and empowering them with increased purchasing capacity. This bolstered consumer demand and contributed to the upward trajectory of Omeprazole prices. Additionally, the escalating cost of pyridine, a critical raw material, further fueled the upward pressure on prices. In conclusion, the quarter-ending price for Omeprazole in France stood at USD 62985 per metric ton CFR Le Havre. The pricing landscape for Omeprazole in Europe during Q1 2024 can be characterized by moderate price increases driven by factors such as consumer demand and logistical challenges.
For the Quarter Ending December 2023
North America
In the fourth quarter of 2023, the Omeprazole market in North America experienced several significant factors that impacted prices. The overall market dynamics were influenced by various factors, including trading activity, currency fluctuations, and patterns of inflation. Firstly, the overall market witnessed an escalation in prices due to moderation of inflation and sustained demand from the healthcare and pharmaceutical sectors. This led to an increase in consumer spending and pushed the Omeprazole prices upward.
Furthermore, the decline in prices in major exporting countries supported the downward trend in Omeprazole prices. The United States, in particular, experienced a decline in consumer confidence and a decrease in demand due to the persistent concerns regarding elevated interest rates and inflationary pressures. However, the strengthen of the US dollar against foreign currencies, particularly from major exporting countries like China, contributed to cost-effective imports, ensuring a steady supply in the domestic market.
Despite these factors, the Omeprazole market in North America remained relatively stable, with minimal fluctuations in prices throughout the quarter. The quarter ending price of Omeprazole (USP, FDA) CFR Houston in the USA was USD 62335/MT.
APAC
The fourth quarter of 2023 proved to be a challenging period for the Omeprazole market in the APAC region. The top three factors that affected the market and prices during this quarter were the contraction in China's manufacturing sector, weak demand both domestically and internationally, and a decline in prices of raw material. China, in particular, experienced a notable decline in manufacturing output, which had a significant impact on the overall market sentiment. Additionally, the market faced reduced demand from both local and international consumers, leading to a decrease in orders and sales. The prices of Omeprazole were further affected by the weakness in the Pyridine market, which caused a decline in prices. Looking specifically at China, the prices of Omeprazole experienced a decrease of 7% compared to the previous quarter. This decline can be attributed to the overall weak demand and challenging market conditions. The price of Omeprazole in China at the end of the quarter stood at USD 60250/MT (USP, FDA) FOB Shanghai.
Europe
The fourth quarter of 2023 proved to be a challenging period for the Omeprazole market in Europe. The market experienced an unstable situation, with factors such as subdued consumer sentiments, heightened interest rates, and a surplus of supply impacting prices. Additionally, the lack of available stock, high energy prices, and growing demand from end users contributed to the upward trajectory of prices in France, which experienced the maximum changes. Despite the overall challenges, the market in France remained stable, with steady demand from end consumers and a moderate supply of Omeprazole. However, the market was affected by a lackluster performance in imported goods from prominent exporting countries like China, leading to constrained availability. The price of Omeprazole (USP, FDA) CFR Le Havre in France at the end of the quarter was USD 61540/MT. Overall, the quarter saw a decrease of 6% in prices compared to the previous quarter of 2023. The price comparison between the first and second half of the quarter showed a 2% increase. Despite the challenges faced, the market is expected to improve in the coming months, with increased demand, improved market dynamics, and the replenishment of new inventories.
For the Quarter Ending September 2023
North America
Omeprazole prices in the United States showed a mixed trend in the third quarter. Prices initially grew by 0.60 percent in July due to reasons such as inventory restocking, increasing demand from end-user sectors, and lower imports from key exporting nations such as China. Consumer prices rose by 3.2 percent in July, raising corporate costs and contributing to the hike in omeprazole prices. Prices fell 2.22 percent in August compared to July, owing to a drop in new orders and market consumption. Consumer prices rose 3.7 percent in August, owing mostly to higher gasoline prices. Inflationary pressures weighed on customer purchasing power, resulting in an ample supply of omeprazole, which contributed to driving down prices. However, as a result of various political and economic difficulties, prices jumped 0.89 percent in September. Consistent inflation, sluggish trading activity, and steady demand from end-user sectors are the drivers driving this trend. China has attempted to strengthen trade with Southeast Asian regional allies in recent times despite rising political tensions with the US, which has hurt shipments to the US and kept Omeprazole prices high.
Asia Pacific
Throughout the third quarter, omeprazole prices showed a mixed pattern in the Chinese market. Prices rose 0.51 percent in July due to rising demand from domestic and international markets, as well as a lack of supply in the market. The manufacturing sector remained in the contraction zone but improved in July compared to the previous scenario, reflecting the production efficiency of industrial sectors edged up slightly, owing to the expansion in market demand. Increased inquiries from domestic and overseas markets drove enterprises to raise their selling prices, which aided the upward trend. In August, Prices fell by 2.18 as a result of decreased end-user demand and an adequate supply on the market. The National Bureau of Statistics (NBS) reported that manufacturing activity declined in August for the fifth consecutive month, while services sector activity slowed as consumers continued to restrict their spending. Furthermore, increased interest rates in key export regions contributed to a reduction in omeprazole demand in the international market, exacerbating the downward trend. However, prices rose by 0.94 percent in September with the continuous surge in new orders, implying a growth in the demand for the manufacturing market.
Europe
In the German market, omeprazole prices showed a mixed pattern throughout the third quarter. Prices rose 0.52 percent in July as a result of increasing demand from end-users combined with lower stocks among merchants and suppliers. Furthermore, high heat waves and heavy rainfall in France disrupted transportation networks, resulting in delayed delivery times to satisfy market demand, leading to an increase in Omeprazole prices. The prices decreased in August by 2.15 percent as a result of adequate supply among market suppliers and a decline in consumer demand. Retailers and service providers in the market reported a decline in new orders. Additionally, consumers' confidence was harmed by rising interest rates and inflation, which resulted in a decline in the demand for omeprazole in the domestic market. Nonetheless, prices rose 0.94 percent in September, reflecting a comeback in consumer confidence in the French market. This existing trend could be attributed to a variety of critical factors, including a lack of available stock, high energy prices, and rising end-user demand.
For the Quarter Ending June 2023
North America
The prices of Omeprazole in the US witnessed a decremented trajectory in the second quarter due to increased supply, decreased demand, and reduced APIs (Active pharmaceutical ingredients) prices. The price of Omeprazole decreased by 7.26% in June 2023, in contrast to the levels seen in April. The prices of US imports fell by 4.8% in May and 0.2% in June, causing the increased supply of APIs (Active Pharmaceutical Ingredients), including Omeprazole, in the US market. The consumer price index (CPI) rose 0.2 percent in June after rising 0.1 percent in May, indicating an accelerating pace of inflation that has led to higher prices for energy and food. The US government imposed federal taxes to bring down inflation, subsequently leading to decreased demand for Omeprazole in the market. This puts downward pressure on Omeprazole prices. The PMI (Purchasing Managers’ Index) also dropped to 46.3 in June compared to the beginning of the second quarter, explaining decreased purchasing activity from end consumers. As the demand is less in the market, the market players have reduced the prices of Omeprazole to clear their existing stock.
Asia Pacific
The prices of Omeprazole in China showed a downward trend in the second quarter. The price of Omeprazole decreased by 7.61% in June 2023, in contrast to the levels seen in April. There were several factors responsible for this downward trend, such as reduced demand from end consumers, increased supply in the market, and a lowering of trade activities. China’s official manufacturing Purchasing Managers’ Index (PMI) also declined to 49.0 in June from 49.2 in April, indicating a contraction of manufacturing activity in China. The Chinese factory activity slowed down due to weakened demand and a decline in an overall new order. Market participants have reduced the prices of Omeprazole to clear their inventories in order to maintain profit margins. The export of APIs to the international market also decreased due to fading COVID-19 pandemic and climate change in China that disrupted the supply chain and transport infrastructure, leading to an increased supply of Omeprazole in the Chinese domestic market. This put downward pressure on omeprazole prices.
Europe
The prices of Omeprazole declined significantly by 7.46 percent in June 2023 compared to levels noticed in April. The factors responsible for this declining trend include increased supply and decreased demand from downstream industries. The official Purchasing Managers’ Index (PMI) of France declined throughout the second quarter and settled at 46 in June 2023. This indicates the decline in purchasing activity and the drop in new orders from end consumers supporting the weakened demand for Omeprazole in the market. The shipping cost also decreased in the second quarter, which increased the supply of Omeprazole in the domestic market. Also, the ease of some of the protocols on the imports of generic medicines has increased the availability of generic versions of Omeprazole, leading to a further decrease in prices. Apart from that, Omeprazole APIs prices declined in exporting countries like India and China, leading to the decremented trend in Europe. In addition, the inflation rate decreased in the second quarter of Europe, further explaining the lower prices of Omeprazole in the market.
For the Quarter Ending March 2023
North America
Omeprazole market prices in the North American region display an upward trend in the first quarter of 2023. Prices increased at the beginning of Q1, which was fuelled by a sharp increase in downstream inquiries and a rise in demand from the food and pharmaceutical industries. Additionally, after the New Year's celebrations were over, market participants concentrated on placing new orders and raised the prices for the last of the domestic market's supplies. In addition, imports from China increased significantly, which further kept prices high. However, with the termination of Q1-2023, the prices went down stably owing to a decrease in inquiries from the domestic market coupled with sufficient stockpiles. With this, the prices of Omeprazole in the United States were settled at USD 161780/MT in the United States.
Asia
Omeprazole prices in the Asia Pacific region, particularly in China, have increased throughout the first quarter of 2023. An increase in inquiries from the domestic and international markets was attributed to this price trend. Due to the approaching CNY (Chinese New Year), manufacturers also increased their production capacity at the beginning of January. This was done to avoid shortages or delays in shipments and to stockpile their inventory to satisfy local demand. In addition, the Chinese markets maintained their optimism in line with the month-long improvement in trade activity and demand dynamics. The termination of Q1 2023 further showed a weaker price trend for Omeprazole due to a decrease in international inquiries to a level that resulted in higher stockpiles for merchants and shipments at the ports. With this, the prices for Omeprazole were recorded at USD 149650 /MT in China.
Europe
During the first quarter of 2023, Omeprazole prices in Europe followed the trend of the APAC region. Prices increased by the start of the first month of Q1 because of improved customer inquiries combined with low stock levels. The general market trend throughout Q1 was further influenced by a slowdown in inflation and eased trade activity. However, until the end of Q1, orders from end-user industries remained above average, supporting strong demand and encouraging traders and local retailers to keep their shelves stocked. However, the prices for Omeprazole declined in the German market in the month of March. With these figures, the price was noted at USD 172655/MT.
For the Quarter Ending December 2022
North America
The North American market for Omeprazole experienced fluctuating sentiment in the fourth quarter of 2022 due to varying demand from downstream pharmaceutical sectors. Omeprazole prices in the US market increased by 4.3% till November and were estimated at USD 158600/MT; however, prices marginally decreased to USD 155600/MT in December. There were supply chain interruptions from a major exporting country, primarily China, due to the Golden Week holiday in the early week of October and subsequent Covid limitations. Though, the orders from downstream pharmaceutical companies were high due to low stocks, which boosted trader confidence in the domestic market. By the conclusion of the quarter, improvement in import frequency from Chinese ports resulted in sufficient market supply, which caused the cost to be slightly lower. Additionally, the demand from the downstream pharmaceutical sector decelerated in December as buyers purchasing interest waned amid the year-end season and waiting for new supply.
Asia- Pacific
In the Asia Pacific region, the Omeprazole market revealed an assorted sentiment with price fluctuations during the entire fourth quarter of 2022. An increment of 3.5% in Omeprazole's price trend was seen in the first half of Q4, with prices settling at USD 145080/MT in November. Limited supplies among local retailers because of the slowdown in manufacturing activities during the Golden Week holidays in the initial week of October stimulated the rising price trend in the market. Also, with an increase in COVID cases, some parts of the country moved into lockdown and continued to cause instability in API exports. Later, in December, the manufacturers slowed down their production and were mainly focused on selling off their stocks even at cheap rates due to the ongoing yearlong destocking season. Thus, by the quarter ending December, prices of Omeprazole were estimated at USD 143655/MT in China.
Europe
Omeprazole had oscillating market dynamics during the fourth quarter of 2022 in Europe. Omeprazole prices in the French market rose to USD 172500/MT till November due to reduced import activity from China over the Golden Week vacation and zero Covid-19 limitations, which resulted in low supplies in the local market. Omeprazole prices, however, fell 1.3% in December, settling at USD 170325/MT in France due to declining demand from the downstream pharmaceutical and nutraceutical sectors, which had impacted the French market's fundamentals and led to a price reduction. Domestic retailers also had adequate inventory to fulfill demand generally, which led to a downward trend towards the end of the quarter.
For the Quarter Ending September 2022
North America
Due to growing demand from the North American end-user pharmaceutical industry, CFR Houston prices in the US market for Omeprazole API soared from USD 155900/MT in July to USD 160000/MT in August. Omeprazole API is mainly imported as an essential ingredient for finished drugs from China; however, zero-covid regulation severely limited its distribution to an overseas countries. Along with this, some Chinese industrial facilities were undergone maintenance because of the heat wave and a power deficit, which impacted trading activities. However, prices dropped in September and settled at USD 152000/MT as retailers in the country had enough inventory to meet all downstream demand due to a resume in trade and purchasing activities by the end of the quarter.
Asia Pacific
In the APAC region, the Omeprazole API price trend dipped in the first half of the third quarter of 2022. The FOB Shanghai prices for the product in China first fell to USD 138400 per MT in August before rebounding to USD 140100 per MT in September. The pharmaceutical sector's sluggish demand significantly impacted the price chart for this product during H1 of Q3. Significant suppliers, however, put off placing sizable orders because of unanticipated occurrences like the country's terrible weather and power outages. When the markets resumed after the suspension, certain production facilities undertook maintenance, which also had a negative effect. Later, in the second half, demand from the pharmaceutical business increased amidst limited stocks among domestic merchants.
Europe
The third quarter of 2022 in Europe commenced with an increase in CFR Le Havre negotiations for Omeprazole API in France. Europe's already difficult economic condition was made even more complicated by the unrest in Russia and Ukraine and by the lockdown and port restrictions in China (a major supplier). The prices were evaluated at USD 170000 per MT in August before falling to USD 162000 per MT in September. However, offtakes from the end-user pharmaceutical industry were weak at the start of the second half of the quarter and worsened in the latter weeks of September because of excessive inventories in the German domestic market.
For the Quarter Ending June 2022
North America
The Omeprazole API market witnessed a stable trend in the North American region in the second quarter of 2022. The market was stable due to steady demand and surplus availability of inventories, impacting the price dynamics of Omeprazole in the region. Demand from the downstream pharmaceutical and other industries has declined throughout Q2 2022. Omeprazole is taken with an Antacid and belongs to the class of proton pump inhibitors for treating stomach-related infections. The upstream energy costs experienced fluctuation on the higher side due to route disruption and increased transportation charges, and the price stabilized owing to enough inventories and existing stock. Towards the end of Q2 of 2022, Omeprazole prices were assessed at USD 153400/MT for CFR Houston during June 2022.
Asia- Pacific
During the second quarter of 2022, the Omeprazole market has declined in the Asia Pacific region amid stable demand fundamentals. Demand from the downstream pharmaceutical sector and other industries has eased throughout Q2 2022. Moreover, Rupee depletion against the dollar also impacted the price dynamics of Omeprazole in the second quarter of 2022. The prices increased owing to market fluctuations witnessed by the costs of Omeprazole. At the commencement of the first half of Q2 2022, the prices of Omeprazole surged with high demand and limited stock availability. Towards the end of the quarter, Omeprazole prices were recorded to follow a plunging trend with a total declination of 9.3%, and values settled at INR 3050350/MT for Ex-Vapi in June 2022.
Europe
Omeprazole market dynamics in the European region showed fluctuations on the back of geopolitical tension between European countries. With the stable demand from the downstream medical industry, such as stomach-related diseases, etc., prices surged in the first half of Q2 2022 due to geopolitical tension and supply disruptions from major Asian exporting countries. Also, the upstream energy prices exhibit slight flotation owing to increased freight charges and logistics shortages. At the onset of the second half of quarter 2, the trade routes showed relief, resulting in a recommencement in trading activities in the European market. Towards the end of Q2 of 2022, Omeprazole prices were assessed at USD 162400/MT for CFR Le Havre in June 2022.
